References
- RavehDMuallem-ZilchaEGreenbergAWiener-WellYSchlesingerYYinnonAMProspective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin/tazobactam and meropenemQJM200699639740616682440
- SolomonDHVan HoutenLGlynnRJAcademic detailing to improve use of broad-spectrum antibiotics at an academic medical centerArch Intern Med2001161151897190211493132
- LevySMultidrug resistance: a sign of the timesN Engl J Med199833819137613789571260
- ThuongMShortgenFZazempaVGirouESoussyCJBrun-BuissonCAppropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluationJ Antimicrob Chemother200046350150810980183
- Hamad Medical CorporationPrescribing and Using Anti-Microbial Agents Policy/Procedure, Policy no CL 7197DohaHamad Medical Corporation2006 [updated 2012]
- PestotnikSLClassenDCEvansRSBurkeJPImplementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomesAnn Intern Med1996124108848908610917
- YoungMPloskerGLPiperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infectionsPharmacoeconomics200119111135117511735679
- KhanFYElshafieSSAlmaslamaniMEpidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based studyTravel Med Infect Dis20108637738721074495
- ElhananGSarhatMRazREmpiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infectionJ Infect19973532832889459403
- BerildDMohseniADiepLMJenseniusMRingertzSHAdjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costsJ Antimicrob Chemother200657232633016387751
- AhkeeSBarzalloMRamirezJEmpiric antibiotic therapy in patients without documented infectionInfect Med199613800802